September 9, 2013, Parsippany, NJ, USA – Diagnostica Stago Inc., offers expertise through two free electronic resources to educate healthcare professionals on hemostasis and thrombosis. The Stago-EdVantage web site and iHemOStasis app for the Apple® iPad® both offer ways to increase hemostasis knowledge, understand clinical situations, therapies and detection methods, and apply practical skills to patient care.
December 2013 - Essex Junction, Vermont – Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation’s U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% L...
January 2014, Parsippany, NJ, USA – Diagnostica Stago Inc. announces launch of STA® – Apixaban Calibrator and Controls for use with the STA® - Liquid Anti-Xa assay (catalog #s 00311US and 00322US). The bar-coded, automation-ready calibrators and controls expand the utility of STA® - Liquid Anti-Xa for specific measurement of apixaban activity in plasma for research purposes. The chromogenic STA® - Liquid Anti-Xa wit...
January 2014, Parsippany, NJ, USA – Diagnostica Stago Inc. introduces Cy-Quant VASP/P2Y12 (cat # 01076) for examination of platelet responsiveness to specific platelet ADP receptor (P2Y12) antagonists and their in vitro effects in fresh human whole blood. Cy-Quant VASP/P2Y12 is an enzyme-linked immunosorbent assay (ELISA) that can be used with any plate reader reporting 450 nm wavelengths.
January 2014, Parsippany, NJ, USA – Diagnostica Stago, Inc. introduces Megamix-Plus SSC (cat # 01078) and Megamix-Plus FSC (cat # 01077), for detection of procoagulant microparticles on both side-scatter and forward-scatter flow cytometers. Microparticles are tissue factor-bearing phospholipid vesicles that are a source of procoagulant phospholipids. Microparticle levels have been studied in several pathologies inc...
Diagnostica Stago, Inc., (DSI) is an industry leader in the science of hemostasis and thrombosis. Stago provides the total commitment of global resources and responsiveness, coupled with cutting edge technology and reliability. DSI is dedicated to continually developing and providing the very best hemostasis products, technical support, and services.
At Stago, we work hard everyday to ensure we are providing best-in-class products and services for the benefit of our laboratory professional customers and the hemostasis community. We consistently improve our products and services to meet the demands of the ever changing laboratory landscape. Stago is proud to announce that for the second year in a row it has won the Northface Award for Customer Service Excellence by the Omega Management Group.
July 6 - 10, 2014
July 27 - 31, 2014
October 19 - 23, 2014
Did you know?
Von Willebrand had first described in 1926 a hemorrhagic familial syndrome, inherited in a dominant manner, in a small ethnic group of Aaland islands, located in the Baltic sea, between Sweden and Finland.